Steinberg v. PA State Board of Pharmacy

CourtDistrict Court, M.D. Pennsylvania
DecidedJuly 18, 2022
Docket1:21-cv-01652
StatusUnknown

This text of Steinberg v. PA State Board of Pharmacy (Steinberg v. PA State Board of Pharmacy) is published on Counsel Stack Legal Research, covering District Court, M.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Steinberg v. PA State Board of Pharmacy, (M.D. Pa. 2022).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF PENNSYLVANIA NORMAN STEINBERG, ) CIVIL ACTION NO. 1:21-CV-1652 Plaintiff ) ) v. ) ) (ARBUCKLE, M.J.) PENNSYLVANIA STATE BOARD ) OF PHARMACY, et al., ) Defendants )

MEMORANDUM OPINION Charles Hartwell’s Motion to Dismiss (Doc.26)

I. INTRODUCTION The Commonwealth revoked Norman Steinberg’s license to practice pharmacy after he plead guilty to a federal crime. In turn, Mr. Steinberg filed this civil rights suit, alleging that the administrative proceedings were chock full of illegality, and that a dragnet of various actors conspired to violate his civil rights. As relevant to the pending Motion to Dismiss, Mr. Steinberg alleges that Charles Hartwell, his former attorney, knew the Commonwealth was violating his rights, but failed to stop it. Therefore, Mr. Steinberg claims that Mr. Hartwell is liable to him under 42 U.S.C. § 1986. However, that law requires allegations of a racial or class based discriminatory animus, which is not present in Mr. Steinberg’s pleadings. So, I will grant Mr. Hartwell’s Motion to Dismiss. II. BACKGROUND AND PROCEDURAL HISTORY This pro se, fee paid civil action began on September 27, 2021, when Norman

Steinberg (“Plaintiff” or Mr. Steinberg) filed a Complaint. (Doc. 1). On January 5, 2022, Plaintiff amended his Complaint by right, so that is now the operative pleading. (Doc. 21). Plaintiff names K. Kalonji Johnson, Theresa M. Talbott, R. Ph., Robert B. Frankil, R. Ph., Thomas P. Carey, Ed.D., Patrick M. Green, Esq., Melanie

A. Zimmerman, R. Ph., Juan A. Ruiz, Esq., Kerry E. Maloney, Esq., Theodore Stauffer and Charles S. Hartwell, Esq. as defendants.1 All parties, including Charles Hartwell, moved to dismiss the Amended Complaint on February 18 and 19, 2022.

(Docs. 26, 27). As we are in the motion to dismiss stage, I will take all facts presented in the Amended Complaint as true. Mayer v. Belichick, 605 F.3d 223, 229 (3d Cir. 2010). Plaintiff, a previously licensed pharmacist in Pennsylvania, was indicted in

December 1999 by federal prosecutors in the Eastern District of Pennsylvania for violations of Controlled Substances Act. (Doc. 21, ¶ 20). Pursuant to a plea agreement, Plaintiff plead guilty for failing to maintain proper records for the sale,

delivery, or other disposition of controlled substances, in violation of 21 U.S.C. §

1 All Defendants besides Mr. Hartwell are Commonwealth employees and are either members of the State Board of Pharmacy, counsel to the Board, or employees of the State Bureau of Professional and Occupational Affairs. 843(a)(4)(A).2 (Id. at ¶ 21). Because of his guilty plea, Plaintiff believed his pharmacy license would be automatically suspended for one year. (Id. at ¶ 25).

However, the Pennsylvania State Board of Pharmacy (the “Board”) or the Bureau of Professional and Occupational Affairs (the “Bureau”) did not pursue disciplinary action. (Id. at ¶ 26).

Believing that his one year mandatory suspension had come and passed, Plaintiff reapplied on March 21, 2014, for a reinstatement of his pharmacy license. (Id. at ¶ 32). After the Board denied three of his applications for failing to provide the appropriate documentation, on November 27, 2015, the Board reinstated

Plaintiff’s license. (Id. at ¶ 42). On July 11, 2016, a Commonwealth prosecutor from the Bureau issued a Show Cause Order, alleging that Plaintiff’s license should be subject to discipline

2 “From January 3, 1996, to April 30, 1997, [Plaintiff], trading as Chelten Pharmacy, violated the federal Drug Abuse Prevention and Control Law, 21 U.S.C. §§ 801-971, specifically Section 843(a)(4)(A) of the statute, when he knowingly or intentionally omitted material information from records required by law to be made, kept, and filed, including records of sale, delivery, or other disposition of approximately 410,000 tablets containing alprazolam, commonly known as Xanax, which is a Schedule IV controlled substance.” Steinberg v. Bureau of Prof’l Affairs State Bd. of Pharmacy, 2021 WL 3642336, *1 (Pa. Commw. Ct. Aug. 18, 2021). The Court may take judicial notice of another court’s memorandum opinion. Sands v. McCormick, 502 F.3d 263, 268 (3d Cir. 2007) (“[W]e noted that judicial proceedings constitute public records and that courts may take judicial notice of another court's opinions.”). pursuant to Section 5(a)(2) of the Pharmacy Act.3 (Id. at ¶ 46). Plaintiff then retained Charles Hartwell to represent him. (Id. at ¶ 50). Following a hearing, the hearing

examiner recommended to the Board that Plaintiff’s license be suspended, a more severe penalty than the prosecutor recommended. (Id. at ¶ 69). On October 17, 2017, the Board “agreed to revoke Plaintiff’s license in executive session.”4 (Id. at ¶ 74).

Almost three years later, on June 16, 2020, the Board unanimously voted to suspend Plaintiff’s license. (Id. at ¶ 83). Plaintiff, with Mr. Hartwell representing him, appealed the Board’s decision to the Commonwealth Court. (Id. at ¶¶ 90-94). Plaintiff wanted Mr. Hartwell to raise

a due process challenge, but he did not do so. (Id.). The Commonwealth Court affirmed the Board’s decision. (Id.). While Plaintiff pleads nine causes of actions against various Defendants, his

claims can be distilled into three categories. First, Plaintiff claims he was deprived of due process in his administrative hearings because there was a commingling of prosecutorial and adjudicatory functions. Plaintiff bases this on two claims: (1) the Board forwarded his application materials to prosecutors and (2) Defendants Ruiz

and Maloney were former prosecutors who handled his case in 2005, and when they

3 That law, codified in 63 P.S. § 390-5(a)(2) gives the Board the power to revoke or suspend a pharmacist’s license if they have pleaded guilty “to any offense in connection with the practice of pharmacy. . . .” 4 Defendants Talbot, Frankil, and Greene voted in favor of the motion. (Id. at ¶ 76). became Board counsel, they improperly advised the Board. Second, he alleges that board acted with undue delay/an improper purpose when it waited three years

between a preliminary decision and making its final decision to revoke Plaintiff’s license. Third, he alleges that the Board violated the Equal Protection Clause because it irrationally treated him differently compared to other similarly situated

individuals. He believes that 42 U.S.C. §§ 1983, 1986, and 1986 give him a cause of action for the aforementioned wrongs. As applicable to Mr. Hartwell, Plaintiff claims that had “first-hand knowledge in 2016 that . . . [there] was a due process violation against Plaintiff, and having

power to prevent the perpetuation of the same, both neglected and refused to do so . . .” (Id. at ¶ 140). Plaintiff further states that Mr. Hartwell’s representation of him was a conflict of interest because he was a Board prosecutor in 2005, and if he

properly pursued a one year suspension, then a longer suspension (like the one he received) would have been foreclosed. (Id. at ¶ 142). As such, Plaintiff believes Mr. Hartwell took part in violating Plaintiff’s civil rights, and he is liable to him under 42 U.S.C.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Steinberg v. PA State Board of Pharmacy, Counsel Stack Legal Research, https://law.counselstack.com/opinion/steinberg-v-pa-state-board-of-pharmacy-pamd-2022.